Long-Term Effects Secondary to Cancer Therapy in Adults Completed Phase Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0038922 (Long-Term Effects Secondary to Cancer Therapy in Adults)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00755313Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer